Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ACCELERATED TRANSMISSION PROTOCOL

K-Number: K955060 · 1996-04-08

ApplicantInstromedix, Inc.
Decision Date1996-04-08
Product CodeDXH
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ACCELERATED TRANSMISSION PROTOCOL is the device name listed in this FDA 510(k) record. The listed applicant is Instromedix, Inc.. It received FDA 510(k) clearance on 1996-04-08 under 510(k) number K955060. The device is classified under product code DXH. It was reviewed by the CV advisory panel. Product code DXH falls under the category of Hematology, which includes devices for blood cell counting, coagulation testing, and hemoglobin analysis. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ACCELERATED TRANSMISSION PROTOCOL?

ACCELERATED TRANSMISSION PROTOCOL is a medical device that received FDA 510(k) clearance on 1996-04-08. The listed applicant is Instromedix, Inc.. The 510(k) number is K955060.

When did ACCELERATED TRANSMISSION PROTOCOL receive FDA 510(k) clearance?

ACCELERATED TRANSMISSION PROTOCOL received FDA 510(k) clearance on 1996-04-08, under 510(k) number K955060.

Who is the listed applicant for ACCELERATED TRANSMISSION PROTOCOL?

The FDA 510(k) record lists Instromedix, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ACCELERATED TRANSMISSION PROTOCOL?

The FDA product code for ACCELERATED TRANSMISSION PROTOCOL is DXH. This falls under the Hematology category.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Instromedix, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K964408POSEIDON CARDIAC MONITORING SYSTEM (PCMS)K964036CARDIOMAGIC 2000 SOFTWAREK951096LIFESIGNS RECEIVING CENER 2000 TRANSTELEPHONIC RECEIVERK945476HEARTHWATCH III(TM)K950003CARDIOMAGIC(R) SOFTWARE ENHANCEMENTSK944362HEARTCARD CARDIAC EVENT MONITOR

View all 32 devices →

Related Devices (Code: DXH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K250233PreemptiveAI Clinical SDKMeasure Labs, Inc. (Dba Preemptiveai, Inc.)K250258HeartBeam AIMIGo with 12-L ECG Synthesis Software SystemHeartbeam, Inc.K243438MEMO Patch M (MPT-E08R-UNC01)Huinno Co., Ltd.K243981Hexoskin Medical System (7100-00016)Carre Technologies, Inc.K243003VitalSigns 1-Lead Holter (VSH101)VitalSigns Technology Co., Ltd.K233521QT ECG (QTERD100)QT Medical, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑